CSF biomarkers cutoffs: the importance of coincident neuropathological diseases-Reference-Cited by-同舟云学术

CSF biomarkers cutoffs: the importance of coincident neuropathological diseases

Published:2012-04-22 Issue:1 Volume:124 Page:23-35
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Toledo Jon B.,Brettschneider Johannes,Grossman Murray,Arnold Steven E.,Hu William T.,Xie Sharon X.,Lee Virginia M.-Y.,Shaw Leslie M.,Trojanowski John Q.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00401-012-0983-7.pdf

Reference69 articles.

1. Acosta-Baena N, Sepulveda-Falla D, Lopera-Gomez CM et al (2011) Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer’s disease: a retrospective cohort study. Lancet neurology 10(3):213–220

2. Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):270–279

3. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin 64 Band, Verlag von Georg Reimer

4. Bian H, Van Swieten JC, Leight S et al (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70(19 Pt 2):1827–1835

5. Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6(3):131–144

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy;Brain Sciences;2024-08-26

2. Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis;Alzheimer's Research & Therapy;2024-04-12

3. Evaluating the Effect of Alzheimer's Disease‐Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy;Annals of Neurology;2024-04-05

4. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases;Acta Neuropathologica Communications;2024-03-27

5. Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome;npj Parkinson's Disease;2023-08-17